Point de repère destin Fait parti visa staph aureus printemps Perth Blackborough LEurope
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
MRSA. Staphylococcus aureus methicillin resistant
JCI - Antimicrobial resistance: the example of Staphylococcus aureus
Vancomycin-Intermediate/Resistant Staphylococcus aureus Laboratory Testing Algorithm | HAI | CDC
Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system | Scientific Reports
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications | Clinical Microbiology Reviews
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea | Scientific Reports
VISA/VRSA Infections
Prevalence of MRSA/MSSA and VRSA/VISA from Staphylococcus aureus isolates. | Download Table
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Vancomycin intermediate resistant Staphylococcus aureus (VISA), morphology and microscopic appearance of Staphylococcus aureus, colony morphology on agar, clinical significance.
Staphylococcus aureus and Staphylococcus epidermidis